Calcium dioxido(dioxo)chromium

Calcium dioxido(dioxo)chromium is an inorganic compound with the chemical formula CaCrO4 and molecular weight of 156.07 g/mol. This calcium chromate salt contains hexavalent chromium and is classified as a Category 1B carcinogen. The substance appears as a yellow crystalline solid and is highly regulated due to its significant health and environmental hazards, requiring strict handling protocols in industrial applications.

Calcium dioxido(dioxo)chromium is a yellow crystalline solid at room temperature with the molecular formula CaCrO4. The compound is moderately soluble in water and exhibits typical ionic compound characteristics. Its molecular weight is 156.07 g/mol, and it contains hexavalent chromium, which contributes to its oxidizing properties and high toxicity profile.

Calcium dioxido(dioxo)chromium is primarily used as a corrosion inhibitor in industrial applications, particularly in metal treatment and surface protection processes. It serves as an oxidizing agent in chemical synthesis and is utilized in specialized industrial processes requiring chromium compounds. Due to its carcinogenic properties, its use is heavily restricted and limited to essential industrial applications with appropriate safety measures.

Calcium dioxido(dioxo)chromium requires strict safety protocols including respiratory protection, chemical-resistant gloves, and protective clothing due to its carcinogenic and acute toxic properties. Work must be conducted in well-ventilated areas or under fume hoods to prevent inhalation. Eye protection is mandatory, and direct skin contact must be avoided at all costs. Regular health monitoring of exposed workers is essential.

Calcium dioxido(dioxo)chromium must be stored in a cool, dry, well-ventilated area away from incompatible materials such as reducing agents and organic compounds. Containers should be tightly sealed and labeled according to GHS requirements. Storage areas must be secure with restricted access due to the carcinogenic nature of the substance, and emergency procedures should be readily available.

Immediate action is required for any contact with calcium dioxido(dioxo)chromium. For skin contact, remove contaminated clothing and flush with copious amounts of water for at least 15 minutes. If inhaled, move to fresh air immediately and seek medical attention. For eye contact, rinse thoroughly with water and remove contact lenses if present. Seek immediate medical attention for all exposure incidents.

Calcium dioxido(dioxo)chromium must be disposed of as hazardous waste through licensed waste management companies specializing in carcinogenic materials. The substance cannot be disposed of in regular waste streams due to its environmental toxicity and carcinogenic properties. All disposal must comply with local and European waste regulations, including proper documentation and tracking throughout the disposal process.

Calcium dioxido(dioxo)chromium is classified as ADR Class 9 (miscellaneous dangerous goods), Packing Group III for transport purposes. Proper packaging, labeling with GHS pictograms (GHS07, GHS08, GHS09), and documentation are required. Transport must comply with dangerous goods regulations, and vehicles must carry appropriate emergency response information and safety equipment for handling potential incidents during transit.

Calcium dioxido(dioxo)chromium is subject to extensive European regulations including REACH registration requirements and CLP classification as a Category 1B carcinogen. The substance carries GHS pictograms for health hazards and environmental dangers, requiring comprehensive safety data sheets and worker protection measures. Its use may be restricted under various national and European chemical safety regulations due to its carcinogenic properties.

Calcium dioxido(dioxo)chromium is available through OYSI, a European distributor of specialty chemicals with expertise in handling regulated substances. As a specialized chemical distributor, OYSI provides proper documentation, safety data sheets, and regulatory compliance support for this highly regulated carcinogenic compound. Contact OYSI directly for availability, technical specifications, and regulatory guidance for your specific application requirements.